Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study

Background A variety of cutaneous human papillomaviruses (HPV) are detectable in genital epithelial lesions in men and non-melanoma skin cancer patients. It remains unclear whether these viruses are associated causally with skin lesions. To date, no study has prospectively examined the association between cutaneous HPV seropositivity and development of external genital lesions (EGLs) in men. Objectives To examine the association between seropositivity to cutaneous HPV types and the risk of subsequent development of EGLs. Methods A nested case-control study including 163 incident EGL cases and 352 EGL-free controls in the HPV Infection in Men (HIM) Study cohort was conducted. Cases were ascertained at each of up to 10 biannual clinical visits and verified through biopsy and pathological diagnoses. EGLs were categorized as condyloma, suggestive of condyloma, penile intraepithelial neoplasia (PeIN), and other EGLs. Archived serum specimens collected at baseline were tested for antibodies against 14 cutaneous HPV types (β types (5, 8, 12, 14, 17, 22, 23, 24, 38, and 47), α type 27, γ type 4, μ type 1, and ν type 41) using a GST L1-based multiplex serology assay. Socio-demographic and sexual behavior data were collected through a questionnaire. Using logistic regression, adjusted odds ratios (AOR) and 95% confidence intervals (CI) were estimated. Results Overall, seropositivity to ≥1 cutaneous HPV type (any-HPV) and ≥1 β types (any-β) was 58.3% and 37.5% among other EGL cases, 71.6% and 46.8% among condyloma, 66.8% and 50.0% among PeIN, and 71.9% and 38.4% among controls, respectively. Type-specific seropositivity was most common for ɤ-HPV 4, μ-HPV 1, and β-HPV 8. No statistically significant association was observed between any-HPV, any-β, and type-specific HPV seropositivity and subsequent development of EGLs across all pathological diagnoses. Conclusions Overall, seropositivity to cutaneous HPV was common among men; however, it appears that cutaneous HPV is not associated with the development of genital lesions in men.

[1]  A. Giuliano,et al.  Genital Human Papillomavirus Infection Progression to External Genital Lesions: The HIM Study. , 2016, European urology.

[2]  A. Giuliano,et al.  Human papillomavirus virus (HPV) genotype- and age-specific analyses of external genital lesions among men in the HPV Infection in Men (HIM) Study. , 2015, The Journal of infectious diseases.

[3]  M. Feltkamp,et al.  Human Beta‐papillomavirus infection and keratinocyte carcinomas , 2015, The Journal of pathology.

[4]  T. Gheit,et al.  Cutaneous HPV and skin cancer. , 2014, Presse medicale.

[5]  D. Jukic,et al.  Cutaneous human papillomavirus types detected on the surface of male external genital lesions: a case series within the HPV Infection in Men Study. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[6]  Geoffrey D. Hannigan,et al.  Microbial ecology of the skin in the era of metagenomics and molecular microbiology. , 2013, Cold Spring Harbor perspectives in medicine.

[7]  D. Chouhy,et al.  Analysis of the genetic diversity and phylogenetic relationships of putative human papillomavirus types. , 2013, The Journal of general virology.

[8]  A. Giuliano,et al.  Concordance of human papillomavirus types detected on the surface and in the tissue of genital lesions in men , 2013, Journal of medical virology.

[9]  J. Kelly,et al.  Penile cancer can be prevented or treated pre-emptively , 2013, BMJ : British Medical Journal.

[10]  S. Arron,et al.  Cutaneous Squamous Cell Carcinoma and Human Papillomavirus: Is There an Association? , 2013, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[11]  Vivek Gopalan,et al.  The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis , 2012, Nucleic Acids Res..

[12]  V. Sondak,et al.  Case–Control Study of Cutaneous Human Papillomaviruses in Squamous Cell Carcinoma of the Skin , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[13]  Christian Munk,et al.  Genital warts and risk of cancer: a Danish study of nearly 50 000 patients with genital warts. , 2012, The Journal of infectious diseases.

[14]  S. Kjaer,et al.  Increased incidence of penile cancer and high-grade penile intraepithelial neoplasia in Denmark 1978–2008: a nationwide population-based study , 2011, Cancer Causes & Control.

[15]  L. Naldi,et al.  A Case–Control Study of Betapapillomavirus Infection and Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  William Fulp,et al.  Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study , 2011, The Lancet.

[17]  R. Verhoeven,et al.  Incidence trends and survival of penile squamous cell carcinoma in the Netherlands , 2011, International journal of cancer.

[18]  E. de Villiers,et al.  Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. , 2010, Virology.

[19]  M. Frisch,et al.  Multiple human papilloma virus types in cervical infections: competition or synergy? , 2010, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[20]  M. Pawlita,et al.  Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia. , 2009, The Journal of general virology.

[21]  E. de Villiers,et al.  Characterization of seven novel human papillomavirus types isolated from cutaneous tissue, but also present in mucosal lesions. , 2009, The Journal of general virology.

[22]  J. Bouwes Bavinck,et al.  Epidemiology of cutaneous human papillomavirus infections. , 2009, Cancer treatment and research.

[23]  A. Giuliano,et al.  Burden of invasive squamous cell carcinoma of the penis in the United States, 1998–2003 , 2008, Cancer.

[24]  T. Gambichler,et al.  Penile intraepithelial neoplasia is frequent in HIV-positive men with anal dysplasia. , 2008, The Journal of investigative dermatology.

[25]  Ji‐Hyun Lee,et al.  The Human Papillomavirus Infection in Men Study: Human Papillomavirus Prevalence and Type Distribution among Men Residing in Brazil, Mexico, and the United States , 2008, Cancer Epidemiology Biomarkers & Prevention.

[26]  M. Pawlita,et al.  Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin , 2008, The British journal of dermatology.

[27]  N. Kiviat,et al.  Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. , 2008, The Journal of investigative dermatology.

[28]  M. Pawlita,et al.  Seroprevalence of 34 Human Papillomavirus Types in the German General Population , 2008, PLoS pathogens.

[29]  J. Dillner,et al.  Seroreactivity to Cutaneous Human Papillomaviruses among Patients with Nonmelanoma Skin Cancer or Benign Skin Lesions , 2008, Cancer Epidemiology Biomarkers & Prevention.

[30]  T. Key,et al.  A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition , 2007, International journal of cancer.

[31]  C. Meijer,et al.  Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  M. Karagas,et al.  Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. , 2006, Journal of the National Cancer Institute.

[33]  Markus F Templin,et al.  Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. , 2005, Clinical chemistry.

[34]  E. Velazquez,et al.  Epithelial Lesions Associated with Invasive Penile Squamous Cell Carcinoma: A Pathologic Study of 288 Cases , 2004, International journal of surgical pathology.

[35]  A. Chaturvedi,et al.  Penile carcinoma: a challenge for the developing world. , 2004, The Lancet. Oncology.

[36]  F. Sera,et al.  Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. , 2003, Archives of dermatology.

[37]  E. Dasbach,et al.  The health and economic burden of genital warts in a set of private health plans in the United States. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  R. Westendorp,et al.  Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. , 2003, Cancer research.

[39]  H. Bittard,et al.  Detection of the human papillomavirus and analysis of the TP53 polymorphism of exon 4 at codon 72 in penile squamous cell carcinomas. , 2003, European journal of cancer.

[40]  M. Pawlita,et al.  HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. , 2002, Journal of virological methods.

[41]  M. Pawlita,et al.  A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. , 2001, Journal of immunological methods.

[42]  B. Hansson,et al.  The Ubiquity and Impressive Genomic Diversity of Human Skin Papillomaviruses Suggest a Commensalic Nature of These Viruses , 2000, Journal of Virology.

[43]  H. Pfister,et al.  Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. , 2000, The Journal of investigative dermatology.

[44]  E. de Villiers,et al.  Degenerate and Nested PCR: a Highly Sensitive and Specific Method for Detection of Human Papillomavirus Infection in Cutaneous Warts , 1999, Journal of Clinical Microbiology.

[45]  S. Jabłońska,et al.  Skin autografts in epidermodysplasia verruciformis: human papillomavirus-associated cutaneous changes need over 20 years for malignant conversion. , 1997, Cancer research.